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Abstract
Organophosphate flame retardants (OPFRs) are commonly added to consumer products to reduce
their flammability. Based on levels of OPFRs in indoor environments, human exposure is likely
chronic and ubiquitous. Animal studies suggest that exposure to some OPFRs may result in
adverse health impacts, particularly for tris (1,3-dichloropropyl) phosphate (TDCPP); however,
human data on the impacts of exposure to OPFRs are lacking. To design human studies, more
information is needed on the stability of measured OPFRs in human samples over time. In this
study, we sought to assess the degree of temporal variability of urinary TDCPP and triphenyl
phosphate (TPP) metabolites throughout pregnancy in a cohort of women from central North
Carolina.
Eight pregnant women provided multiple urine samples: 3 during the 18th week of pregnancy, 1
during the 28th week, and 1 shortly after the child’s birth. Bis (1,3-dichloropropyl) phosphate
(BDCPP) and diphenyl phosphate (DPP), the respective metabolites of TDCPP and TPP, were
measured in urine samples using liquid chromatography-tandem mass spectrometry. BDCPP and
DPP were each detected in 38 of 39 urine samples and were not normally distributed. Geometric
mean BDCPP and DPP concentrations were 1.3 ng/mL (interquartile range (IQR): 0.8, 2.7 ng/mL)
and 1.9 ng/mL (IQR: 0.9, 3.5 ng/mL), respectively. BDCPP and DPP were moderately to strongly
reliable over one week (ICC=0.5; 95% confidence interval (CI): 0.4, 0.7 and ICC=0.7; 95% CI:
0.5, 0.8, respectively), and over the entire pregnancy (ICC=0.5 95% CI: 0.3, 0.7 and ICC=0.6;
95% CI: 0.4, 0.7, respectively). These data suggest that exposures to TDCPP and TPP are
widespread and variable for pregnant women, and that a single measure of BDCPP or DPP, taken
in the second trimester, likely captures information on the rank order of exposure throughout
pregnancy.
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Introduction
Flame retardant chemicals have been added to a variety of household products to meet
flammability standards for many years. Until recently, polybrominated diphenyl ethers
(PBDEs) accounted for a large proportion of flame retardants used in household products,
including polyurethane foam and electronics; however, regulatory action and concern over
the persistence, bioaccumulation, and toxicity of PBDEs led to their phase-out and the
introduction of alternative flame retardants (Stapleton, Allen et al. 2008, van der Veen and
de Boer 2012). Organophosphate flame retardants (OPFRs) such as tris (1,3-dichloropropyl)
phosphate (TDCPP) and triphenyl phosphate (TPP) are now among the most commonly
used PBDE alternatives in residential furniture (US Environmental Protection Agency
(EPA) 2005, Stapleton, Klosterhaus et al. 2009, Stapleton, Sharma et al. 2012, van der Veen
and de Boer 2012). In fact, two recent studies demonstrated that TDCPP was the most
commonly applied flame retardant in residential furniture and baby products containing
polyurethane foam (Stapleton, Klosterhaus et al. 2011, Stapleton, Sharma et al. 2012). In
addition, TDCPP and TPP have been detected with high frequency in dust collected from
homes, offices, and automobiles suggesting that the majority of the population receives
chronic exposure to these compounds (Meeker and Stapleton 2010, Carignan, McClean et al.
2013). Inadvertent ingestion of house dust has been shown to be a primary route of human
exposure to PBDE flame retardants, and may be similar for OPFRs. Two recent assessments
have reported ubiquitous detection of urinary OPFR metabolites in the general population
(Carignan, McClean et al. 2013, Meeker, Cooper et al. 2013).
Toxicological data suggests that certain OPFRs may be reproductive toxins and may also
have carcinogenic and neurotoxic properties (National Research Council (NRC) 2000,
Dishaw, Powers et al. 2011, van der Veen and de Boer 2012). An exposure assessment
conducted by the Consumer Product Safety Commission referred to TDCPP as a suspected
carcinogen, and established an acceptable daily dose of 5 micrograms/kg body weight per
day (Babich 2006). Currently, available data are very limited on human exposure or
potential human health effects. Epidemiologic studies, while critically need, are complicated
by the potentially episodic nature of exposure and the short biological half-lives of OPFRs.
Variations in behaviors and movement between different micro-environments may create
within-person variability of OPFRs making it difficult to accurately assess human
exposures. Investigations of prenatal exposures are further complicated by pregnancy-
related changes in metabolism that may contribute to variability in metabolite levels
throughout gestation (Mahalingaiah, Meeker et al. 2008, Braun, Kalkbrenner et al. 2011,
Braun, Smith et al. 2012).
In our present work, we utilize recently developed methods to extract and measure bis (1,3-
dichloropropyl) phosphate (BDCPP) and diphenyl phosphate (DPP), the respective
metabolites of TDCPP and TPP, in urine samples from a group of pregnant women (Cooper,
Covaci et al. 2011). We investigate both the short- and long-term variability in the levels of
OPFR metabolites in urine throughout pregnancy. This information will help inform
exposure assessment in epidemiological studies and aid in the interpretation of results using
single exposure measures to capture information on exposure throughout pregnancy.
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1.2 Materials and methods
1.2.1 Study Population
We recruited 8 pregnant women between December 2011 to May 2012 using flyers placed
in health centers, doctor’s offices, and in public settings around Chapel Hill, North Carolina.
Women provided demographic information and urine samples during pregnancy. In the 18th
week of pregnancy each woman collected a 24-hour urine specimen as well as 2 first
morning voids, approximately 48-hours apart. Women were also asked to provide a first
morning void in the 28th week of pregnancy and a spot urine sample after their child’s birth.
All 8 women provided urine samples during the first 4 sample collection time points and 7
women provided urine samples after the birth of their child (samples collected 1 to 10 days
post-birth). Our final sample consisted of 39 urine specimens. All study protocols were
approved by the institutional review board at the University of North Carolina–Chapel Hill
and all women provided informed consent.
1.2.2 OPFR Analysis
Urine samples were collected in sterile polyethylene specimen containers. Samples were
packed on ice and transported to the lab each day, where they were aliquoted into 15-ml
conical centrifuge tubes and frozen at −80°C until analysis. Extraction and measurement
methods have been described previously (Cooper, Covaci et al. 2011). Briefly, BDCPP and
DPP were measured in urine samples using mixed-mode anion exchange solid phase
extraction and a mass-labeled internal standard (d10-BDCPP and d10-DPP) with analysis by
atmospheric pressure chemical ionization liquid chromatography tandem mass spectrometry
(Cooper, Covaci et al. 2011). For quality assurance purposes we evaluated the recovery of
d10-BDCPP and d10-DPP in all samples, and measured the amount of BDCPP and DPP
levels in laboratory blanks (n=6). The average recoveries of d10-BDCPP and d10-DPP were
72 ± 13 and 62 ±8%, respectively. Very small amounts of DPP, were detected in laboratory
blanks, while BDCPP was not detected. Therefore, the method detection limit (MDL) was
calculated using three times the standard deviation of the blanks normalized to the urine
volume extracted, which was 4.7 pg/mL and 12.7 pg/mL, respectively. Levels of BDCPP
and DPP in urine were corrected for recovery of the mass labeled internal standards. We
explored several methods of imputing values below the method limit of detection, including
the MDL/2 and the MDL/ √2 (Hornung and Reed 1990). Because results were very similar
using alternate methods, we have chosen to present results using the MDL/ √2 for missing
values.
Sample specific gravity (SG) was measured in each urine sample prior to analysis using a
digital handheld refractometer (Atago, Bellevue, WA, USA). All analyses were conducted
using both uncorrected and specific gravity adjusted concentrations account for urine
dilution (Boeniger, Lowry et al. 1993). One participant had very dilute urine (SG=1.004). To
assess the robustness of analyses to including information from this sample we conducted
sensitivity analyses omitting the observation. As excluding the observation had little impact
on results, it was retained in all presented analyses.
1.2.3 Statistical Analyses
1.2.3.1 Descriptive Analyses—All statistical analyses were performed in SAS (SAS
version 9.2; SAS institute, Cary NC). We calculated descriptive statistics for each metabolite
including the geometric mean concentration and selected percentiles (10th, 25th, 50th, 75th
and 90th percentiles). We also examined the distribution of urinary BDCPP and DPP
graphically. Urinary metabolite levels were skewed right. Accordingly, all quantitative
analyses were conducted with natural log-transformed urinary BDCPP and DPP measures.
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We assessed the relationship between urinary BDCPP and DPP concentrations by
calculating spearman correlation coefficients.
1.2.3.2 Variability Assessment—We assessed variability in BDCPP and DPP in three
ways. First, we estimated the short- and long-term variability in BDCPP and DPP
concentrations by calculating interclass correlation coefficients (ICCs). ICCs provide a
measure of the reliability of repeated measures over time and are calculated by taking the
ratio of the between-subject variability to the sum of the between- and within-subject
variability (Rosner 2000). ICC values range from 0, indicating no reproducibility, to 1,
indicating perfect reproducibility. ICCs and 95% confidence intervals were calculated using
a SAS Marco developed by Hamer (1995), and based on the work of Shrout and Fleiss
(1979). ICCs were calculated for samples collected in the 18th week of pregnancy to capture
short-term reliability (3 samples each in 8 women; n=24) and for all sample points to capture
long-term reliability. In analyses of long-term variability, the three samples collected from
each woman during the 18th week of pregnancy were first averaged to avoid inflating ICCs
with measurements taken over a short period of time, and then compared to the samples
taken at 28th week of pregnancy and at birth.
In addition to ICCs, we also conducted analyses to determine how well OPFR metabolite
concentrations from each time point (18 week average, 28th week, and birth samples)
captured the rank order of exposure throughout pregnancy. First, each woman’s geometric
mean metabolite concentration was calculated and women were ranked (GM of 18 week
average, 28th week, and birth samples). Women with the 4 highest GM concentrations were
classified as the “high” exposure group (true high exposure category). Women were then
ranked at each time point based on the concentration in that individual sample (predicted
exposure category). Contingency tables were constructed for each time point comparing the
predicted exposure category to the true high exposure category. Contingency tables form
each time point were then combined into a single table and sensitivity, specificity, positive
predictive value (PPV) and negative predictive value (NPV) were calculated.
1.3 Results
Women participating in our study ranged in age from 28 to 36 years at conception and were
predominantly white (88%) and highly educated (88% had completed graduate education).
All mothers delivered healthy, full-term infants. Both BDCPP and DPP were detected in
nearly all urine samples (97% detect); however, geometric mean urine concentrations varied
considerably from individual to individual. The distribution of BDCPP and DPP
concentrations in urine samples is shown in Table 1 (n=39). Levels of BDCPP and DPP at
each time point were weakly correlated (rs=0.3, p=0.1).
The rank order of women’s urine concentrations was similar over time. Figure 1 shows the
concentrations of BDCPP and DPP measured during the 18th week (average) and 28th week
of pregnancy and shortly after their child’s birth (one woman was missing a sample after the
birth). Examining temporal variability in BDCPP and DPP during the 18th week of
pregnancy using ICCs, we observed moderate to strong reliability (Table 2)(Rosner 2000).
ICCs calculated over the entire course of pregnancy were slightly lower than those for
samples taken over one week but results also suggest moderate reliability over time for
urinary metabolites. In general, correcting for urine dilution using specific gravity decreased
reliability estimates slightly.
Results of the analyses investigating the ability of a single sample to correctly identify a
woman as highly exposed (based on her 3 month geometric mean metabolite level) are
shown in Table 3. Sensitivity, specificity, positive predictive value, and negative predictive
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value were high for both metabolites (range 0.8 to 0.9), suggesting good agreement between
methods of classifying women into the high exposure group (i.e. geometric mean throughout
pregnancy or a single measurement). Results were similar when we used uncorrected
concentrations (data not shown) and specific gravity corrected observations (Table 3).
1.4 Discussion
BDCPP and DPP were detected in nearly all urine samples collected from pregnant women
in North Carolina, suggesting that exposures to TDCPP and TPP are widespread. Our results
are consistent with several small studies which also reported variable, but near ubiquitous
exposure (Cooper, Covaci et al. 2011, Carignan, McClean et al. 2013, Meeker, Cooper et al.
2013). However, geometric mean concentrations were notably higher in our small sample of
pregnant women than those reported in any of the previous studies (approximately 3 to 10
times greater than concentrations reported by Carignan, McClean et al. (2013) or Meeker,
Cooper et al. (2013)). Differences in excretion rates and kidney function during pregnancy
may explain the higher metabolite levels observed in our study cohort relative to other non-
pregnant cohorts.
We observed weak and non-statically significant correlations between urinary DPP and
BDCPP concentrations which may be explained by differences in the sources of exposure to
TDCPP and TPP. While both TDCPP and TPP are used as additive flame retardants in
household products, TPP is also used as a plasticizer and lubricant and in hydraulic fluids
(van der Veen and de Boer 2012). Differences in the metabolism and excretion of TDCPP
and TPP also provide possible explanations for the weak correlation observed in urinary
biomarkers of exposure.
Although the toxicokinetics of TDCPP and TPP in the human body have yet to be explored,
data suggest that they are rapidly metabolized (to BDCPP and DPP, respectively) and are
rapidly eliminated from the body (Lynn, Wong et al. 1981, Nomeir, Kato et al. 1981,
Cooper, Covaci et al. 2011, Cooper, Getzinge et al. (Under Review)). Nonetheless, we
observed moderate to strong reliability in the levels of BDCPP and DPP in urine samples
collected throughout pregnancy and shortly after giving birth. Estimated ICCs for BDCPP
and DPP were similar to those reported by Meeker et al. (2013) for urine samples collected
from adult men over approximately 90 days. These ICCs were higher than those typically
observed from rapidly metabolized compounds with primarily dietary sources (Braun,
Kalkbrenner et al. 2011, Braun, Smith et al. 2012, Bradman, Kogut et al. 2013). For
example, Braun et al. (2011) recently reported an ICC of 0.1 for bisphenol A in a cohort of
pregnant women (3 samples from each woman collected at 16 and 26 weeks gestation and
birth). These data suggest that TDCPP and TPP may come from more continuous sources of
exposure than diet, such as contaminated dust in the home or workplace environments. This
would seem a reasonable hypothesis given that human exposure to PBDE flame retardants in
the US has been demonstrated to occur primarily from exposure to household dust, both in
adults and in children (Stapleton, Eagle et al. 2012, Watkins, McClean et al. 2012).
Additionally, our results suggest that a single urine sample may reasonably capture the rank
order of metabolite concentrations throughout pregnancy; the sensitivity and specificity for a
single urine sample to predict the overall geometric mean were high for both BDCPP and
DPP.
Adjustments for urine dilution have been recommended in the assessment of xenobiotics and
are commonly included in epidemiologic investigations (Boeniger, Lowry et al. 1993). In
this study, we chose to adjust with urinary specific gravity, which is thought to be less
impacted by changes with age, body composition, physical activity, urine flow, time of day,
diet, disease and pregnancy than other measures such as creatinine (Boeniger, Lowry et al.
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1993, Braun, Kalkbrenner et al. 2011). However, our results indicate that adjustment for SG
generally decreased reliability over time, a finding that is consistent with previous
assessments (Meeker, Cooper et al. 2013). There are several possible explanations for this
pattern, including imperfect measures of urine dilution or insufficient methods of adjustment
for dilution (e.g. Sorahan, Pang et al. 2008). Other measures of urine dilution and methods
of correction should be included in future studies of BDCPP and DPP.
Inferences from this study are limited by the small sample size (8 women with a total of 39
measurements) and composition, specifically highly-educated pregnant women, which may
differ substantially from other populations. However, our results are consistent with those
from the only other study to assess the reliability of biomarkers in humans, in which the
study population was composed of adult men (Meeker, Cooper et al. 2013). Follow-up of
our findings in larger cohorts with longitudinal data will provide additional insights.
1.5 Conclusions
Our results demonstrate that exposure to TDCPP and TPP in pregnant women is likely.
Additionally, we observed a high degree of variability in urinary metabolites of TDCPP and
TPP (i.e. BDCPP and DPP) among women in our study population, but moderate to strong
reliability of DPP and BDCPP in ranking women’s exposure levels over time. Thus, while
our analyses were limited by our small sample size and relatively homogeneous study
population of North Carolina pregnant women, these data, provide some confidence that a
single measure of levels during pregnancy may be sufficient in characterizing levels
throughout pregnancy. Further data are needed to identify sources of exposure to OPFRs and
to assess their impact on health.
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Exposures to TDCPP and TPP are widespread and variable for pregnant women.
TDCPP and TPP metabolites were detected frequently in urine samples.
Measures of TDCPP and TPP metabolites were moderately reliable throughout
pregnancy.
A single measure of metabolites captured information on the rank order of exposure
over time.
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Concentrations (ng/mL) of metabolites in urine from repeated samples collected from 8
pregnant women in the18th (averaged across three measurements) and 28th weeks of
pregnancy and at the time of birth. (A) DPP; (B) BDCPP. Colors represent individual
participants. Measured samples are connected with lines to assist in the interpretation of
changes over time.
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Table 2
Interclass correlation coefficients (ICC) for uncorrected and specific gravity-corrected urinary BDCPP and
DPP concentrations for 39 samples among 8 pregnant NC women.
Urinary Metabolite
Week 18 Samples (n=24) All Samples (n=23)
Uncorrected SG*-corrected Uncorrected SG*-corrected
DPP 0.7 (0.5, 0.8) 0.6 (0.4, 0.7) 0.6 (0.4, 0.7) 0.4 (0.2, 0.6)
BDCPP 0.5 (0.4, 0.7) 0.6 (0.4, 0.7) 0.5 (0.4, 0.7) 0.4 (0.2, 0.6)
*
SG-Specific gravity
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Table 3
Sensitivity and specificity analysis for the ability of a urine measurement at 18 week, 28 weeks or after birth,
to correctly classify a high exposure group according GM* metabolite concentration throughout pregnancy
among 8 NC women.
Urinary Metabolite Sensitivity Specificity Positive Predictive Value Negative Predictive Value
DPP 0.8 0.9 0.9 0.8
BDCPP 0.8 0.8 0.8 0.8
*
GM-Geometric Mean
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